LSE - Delayed Quote GBp
Cizzle Biotechnology Holdings Plc (CIZ.L)
1.5500
0.0000
(0.00%)
At close: May 2 at 3:45:37 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Allan John Syms | Executive Chairman | 93k | -- | 1956 |
| Prof. Dawn Coverley | Founder, Chief Scientific Officer & Executive Director | 41k | -- | 1965 |
| Mr. Nigel R. Lee | Finance Director & Executive Director | 37k | -- | 1961 |
Cizzle Biotechnology Holdings Plc
60 Gracechurch Street
6th Floor
London, EC3V 0HR
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Corporate Governance
Cizzle Biotechnology Holdings Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
APTA.L Aptamer Group PLC
0.3850
0.00%
SCLP.L Scancell Holdings plc
10.25
0.00%
IMM.L ImmuPharma plc
3.4400
-1.85%
SAR.L Sareum Holdings plc
17.00
0.00%
POLB.L Poolbeg Pharma PLC
3.0500
-6.15%
KLTO Klotho Neurosciences, Inc.
0.1700
-2.75%
OSRH OSR Holdings, Inc.
1.3700
-2.84%
TCRT Alaunos Therapeutics, Inc.
2.8500
+12.65%
MTNB Matinas BioPharma Holdings, Inc.
0.6398
+4.89%
PALI Palisade Bio, Inc.
0.7870
-3.08%